Trial Profile
Effects of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose Over One Year in Subjects With Type 2 Diabetes Under Diet Control and Exercise.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs D-tagatose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms NEET
- 06 Mar 2020 According to an Alkido Pharmamedia release, Spherix has changed its name to Alkido Pharmamedia.
- 02 Dec 2010 Post-hoc analysis reported in a Spherix media release.
- 07 Oct 2010 Results reported in Spherix media release.